{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T01:58:31Z","timestamp":1773021511947,"version":"3.50.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinical-lymphoma-myeloma-leukemia.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Lymphoma Myeloma and Leukemia"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/j.clml.2019.11.014","type":"journal-article","created":{"date-parts":[[2019,12,27]],"date-time":"2019-12-27T19:42:57Z","timestamp":1577475777000},"page":"305-311","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit"],"prefix":"10.1016","volume":"20","author":[{"given":"Naresh","family":"Bumma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misako","family":"Nagasaka","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Griffin","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0433-9779","authenticated-orcid":false,"given":"Hirotaka","family":"Miyashita","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tahmida","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seongho","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hema M.","family":"Vankayala","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shabbir","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pallavi","family":"Jasti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clml.2019.11.014_bib1","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.mayocp.2012.06.014","article-title":"Incidence of monoclonal gammopathy of undetermined significance and estimation of duration before first clinical recognition","volume":"87","author":"Therneau","year":"2012","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.clml.2019.11.014_bib2","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1056\/NEJMoa054494","article-title":"Prevalence of monoclonal gammopathy of undetermined significance","volume":"354","author":"Kyle","year":"2006","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2019.11.014_bib3","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1182\/blood-2005-03-1038","article-title":"Serum free light chain ratio is an independent risk factor for progression in monoclonal gammopathy of undetermined significance","volume":"106","author":"Rajkumar","year":"2005","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.014_bib4","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1182\/blood-2017-09-807560","article-title":"How I manage monoclonal gammopathy of undetermined significance","volume":"131","author":"Go","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.014_bib6","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jamaoncol.2015.2938","article-title":"Agent Orange exposure and monoclonal gammopathy of undetermined significance: an Operation Ranch Hand veteran cohort study","volume":"1","author":"Landgren","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2019.11.014_bib7","series-title":"Disposition of the Air Force Health Study","year":"2006"},{"key":"10.1016\/j.clml.2019.11.014_bib8","first-page":"153","article-title":"Pesticide exposures and multiple myeloma in Iowa men","volume":"4","author":"Brown","year":"1993","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.clml.2019.11.014_bib9","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1002\/(SICI)1097-0274(199711)32:5<510::AID-AJIM11>3.0.CO;2-5","article-title":"Meta-analyses of multiple myeloma and farming","volume":"32","author":"Khuder","year":"1997","journal-title":"Am J Ind Med"},{"key":"10.1016\/j.clml.2019.11.014_bib10","doi-asserted-by":"crossref","first-page":"6386","DOI":"10.1182\/blood-2009-02-203471","article-title":"Pesticide exposure and risk of monoclonal gammopathy of undetermined significance in the Agricultural Health Study","volume":"113","author":"Landgren","year":"2009","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.014_bib11","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1056\/NEJMoa01133202","article-title":"A\u00a0long-term study of prognosis in monoclonal gammopathy of undetermined significance","volume":"346","author":"Kyle","year":"2002","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.clml.2019.11.014_bib12","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1182\/blood.V126.23.4194.4194","article-title":"Previous Agent Orange exposure is correlated with worse outcomes in patients with multiple myeloma (MM)","volume":"126","author":"Callander","year":"2015","journal-title":"Blood"},{"key":"10.1016\/j.clml.2019.11.014_bib13","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1001\/jamaoncol.2015.3015","article-title":"Association of Agent Orange with plasma cell disorder further evidence","volume":"1","author":"Munshi","year":"2015","journal-title":"JAMA Oncol"},{"key":"10.1016\/j.clml.2019.11.014_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.gde.2015.03.008","article-title":"Genomic heterogeneity in multiple myeloma","volume":"30","author":"Szalat","year":"2015","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/j.clml.2019.11.014_bib15","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.canep.2009.08.005","article-title":"Associations of common variants in genes involved in metabolism and response to exogenous chemicals with risk of multiple myeloma","volume":"33","author":"Gold","year":"2009","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/j.clml.2019.11.014_bib16","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/mc.22175","article-title":"Regulations of p53-targeting microRNAs by polycyclic aromatic hydrocarbons: implications in the etiology of multiple myeloma","volume":"54","author":"Gordon","year":"2015","journal-title":"Mol Carcinog"}],"container-title":["Clinical Lymphoma Myeloma and Leukemia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019321639?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2152265019321639?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T00:34:01Z","timestamp":1761870841000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2152265019321639"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5]]},"references-count":15,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2152265019321639"],"URL":"https:\/\/doi.org\/10.1016\/j.clml.2019.11.014","relation":{},"ISSN":["2152-2650"],"issn-type":[{"value":"2152-2650","type":"print"}],"subject":[],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of Exposure to Agent Orange on the Risk of Monoclonal Gammopathy and Subsequent Transformation to Multiple Myeloma: A Single-Center Experience From the Veterans Affairs Hospital, Detroit","name":"articletitle","label":"Article Title"},{"value":"Clinical Lymphoma Myeloma and Leukemia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clml.2019.11.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}